p16, Cyclin D1, and HIF-1<i>α</i> Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

<table>Locoregional control and disease-free survival stratified by HIF-1<i>α</i> (nuclear) status. </table>

International Journal of Otolaryngology

fig4

Figure 4

Figure 4: p16, Cyclin D1, and HIF-1<i>α</i> Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy 

Figure 4 | p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy 